Activity

Filter

Cancel
Date Panel Item Activity
10 actions
Hereditary Neuropathy_CMT - isolated v1.24 ITPR3 Zornitza Stark Phenotypes for gene: ITPR3 were changed from Charcot-Marie-Tooth disease to Charcot-Marie-Tooth disease, demyelinating, type 1J, MIM# 620111
Hereditary Neuropathy_CMT - isolated v1.23 ITPR3 Zornitza Stark Publications for gene: ITPR3 were set to 32949214
Hereditary Neuropathy_CMT - isolated v1.22 ITPR3 Zornitza Stark Classified gene: ITPR3 as Green List (high evidence)
Hereditary Neuropathy_CMT - isolated v1.22 ITPR3 Zornitza Stark Gene: itpr3 has been classified as Green List (High Evidence).
Hereditary Neuropathy_CMT - isolated v1.21 ITPR3 Zornitza Stark edited their review of gene: ITPR3: Added comment: Additional family with 3 individuals in 2 generations reported in PMID 24627108.; Changed rating: GREEN; Changed publications: 32949214, 24627108; Changed phenotypes: Charcot-Marie-Tooth disease, demyelinating, type 1J, MIM# 620111
Hereditary Neuropathy_CMT - isolated v0.61 ITPR3 Zornitza Stark Marked gene: ITPR3 as ready
Hereditary Neuropathy_CMT - isolated v0.61 ITPR3 Zornitza Stark Gene: itpr3 has been classified as Amber List (Moderate Evidence).
Hereditary Neuropathy_CMT - isolated v0.61 ITPR3 Zornitza Stark Classified gene: ITPR3 as Amber List (moderate evidence)
Hereditary Neuropathy_CMT - isolated v0.61 ITPR3 Zornitza Stark Gene: itpr3 has been classified as Amber List (Moderate Evidence).
Hereditary Neuropathy_CMT - isolated v0.60 ITPR3 Zornitza Stark gene: ITPR3 was added
gene: ITPR3 was added to Hereditary Neuropathy_CMT - isolated. Sources: Literature
Mode of inheritance for gene: ITPR3 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: ITPR3 were set to 32949214
Phenotypes for gene: ITPR3 were set to Charcot-Marie-Tooth disease
Mode of pathogenicity for gene: ITPR3 was set to Other
Review for gene: ITPR3 was set to AMBER
Added comment: Two unrelated families reported: variant segregated in four affected individuals in one family and was de novo in the second family where there was a single affected person. Some evidence for dominant-negative effect.
Sources: Literature